Daily Archives: February 19, 2015

The Language of Risk – FDA’s Evolution of Thought

Posted on February 19, 2015 by Mark Senak

How does the average patient assess the risk of a medical product when deciding whether or not to seek it out? This month, FDA released a new draft guidance document entitled “Brief Summary and Adequate Directions for Use: Disclosing Risk … Continue reading →

Posted in FDA Policy | Comments Off on The Language of Risk – FDA’s Evolution of Thought